Introduction {#Sec1}
============

Keshan disease (KD) is a kind of endemic cardiomyopathy which has a high mortality. It was reported firstly in Keshan County in northeast China in 1935, while the similar cases were found in Nagano Prefecture in Japan and northern mountains in North Korea in the 1950s^[@CR1]^. It is characterized by acute or chronic episodes of heart disorder manifested by cardiogenic shock, arrhythmia, and congestive heart failure with cardiomegaly. The 2010 Statistical Yearbook of Health in China indicates that KD affected 40088 residents in 16 provinces^[@CR2]^. However, molecular mechanism in the pathogenesis of KD remains poorly understood.

At first, there are many studies focused on the roles of selenium deficiency in the pathogenesis of KD. The levels of selenium in the soil and food of the endemic area are significantly lower than the ones in the non-endemic area. The levels of selenium in the blood and hair of the patients with KD are also significantly lower than those in the normal control individuals^[@CR3]^.

Up to now, studies about the expression of abnormal genes in KD patients has become more and more popular. Previously, the different expression genes between the KD patients and normal controls were screened by our whole-genome microarray analysis^[@CR4]^. Then the significant genes were screened out by SAM (significance analysis of microarrays) analysis. Fifty-nine genes were found to be up and nineteen genes down regulated. The function categories of the different genes contained metabolism, transcription, synthesis and modification of proteins, ion channels and transport proteins and cell-to-cell signal transduction^[@CR5]^. In the previous study, nine different expression protein spots were observed between Keshan disease patients and health control ones in 2-dimensional gel electrophoresis images, of which eight were identified by MALDI-TOF-MS^[@CR6]^.

The isobaric tags for relative and absolute quantitation (iTRAQ) labeling and coupled two-dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) have become important techniques in the quantitative proteomics technology due to the high quantitative accuracy and advantages of high throughput^[@CR7]^.

In order to screen significant genes and proteins associated KD and build protein network in this study, the expression levels of the 78 differentially expressed genes observed in our previous KD whole genomics study^[@CR4]^ were evaluated in the peripheral blood of KD patients and healthy controls via an oligonucleotide microarray analysis. Then, Genevestigator online tool was used to forecast the co-expression genes of the differently expressed genes. Finally, an iTRAQ-coupled 2D LC-MS/MS technique was employed to analyze the differently expressed protein in the sera of KD and normal individuals. Differently expressed proteins pathways and networks were analyzed using IPA (Ingenuity pathway analysis) and STRING (search tool for the retrieval of interacting genes) online systems separately. Besides KD, the approach of this study may also provide new insights to the underlying molecular mechanisms of other heart diseases.

Results {#Sec2}
=======

Microarray data analysis {#Sec3}
------------------------

The analysis of microarray data using the fold change criteria ≥3 and ≤0.33, revealed 32 up-regulated genes in KD compared to normal controls were noticed (Table [1](#Tab1){ref-type="table"}). The fold changes ranged from 3.26 to 20.47. Notably, no down-regulated genes were observed.Table 1Differently expressed genes between KD patients and the normal controls.Gene nameDescriptionGene IDFold ChangeTTC25tetratricopeptide repeat domain 25NM03142120.47RMND5Arequired for meiotic nuclear division 5 homolog ANM02278014.23IDH2isocitrate dehydrogenase (NADP(+)) 2, mitochondrialNM00216813.24A2ML1alpha-2-macroglobulin like 1NM_14467010.91FBXO15F-box protein 15NM1526769.32ZDHHC2zinc finger DHHC-type containing 2NM_0163537.74LEF1lymphoid enhancer binding factor 1NM0162697.61FEM1Afem-1 homolog ANM0187087.12CD3GCD3g moleculeNM0000736.57SSBP1single stranded DNA binding protein 1NM0031436.53RASD1ras related dexamethasone induced 1NM-0160846.28SIGLEC8sialic acid binding Ig like lectin 8NM0144425.21ABCC13ATP binding cassette subfamily C member 13NR_0030875.11DIO3iodothyronine deiodinase 3NM0013625.1PDE8Bphosphodiesterase 8BNM0037194.82TNFSF11tumor necrosis factor superfamily member 11NM-0037014.77TNNT2troponin T2, cardiac typeNM0003644.72THBS1thrombospondin 1NM0032464.7ABI3BPABI family member 3 binding proteinNM-0154294.69MGAT3mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferaseNM0024094.68EYA4EYA transcriptional coactivator and phosphatase 4NM0041004.67SEZ6L2seizure related 6 homolog like 2NM2015754.64NUCKS1nuclear casein kinase and cyclin dependent kinase substrate 1NM0227314.3IGF2BP2insulin like growth factor 2 mRNA binding protein 2NM0065483.93KRR1small subunit processome component homologNM_0070433.85GUCD1guanylyl cyclase domain containing 1NM_0314443.82ACSL6acyl-CoA synthetase long-chain family member 6NM0010091853.61C18orf10tubulin polyglutamylase complex subunit 2NM_0154763.43REXO2RNA exonuclease 2NM0155233.40MYBPC3myosin binding protein C, cardiacNM0002563.39EFNA1ephrin A1NM0044283.28CYP2B6cytochrome P450 family 2 subfamily B member 6NM0007673.26

qRT-PCR validation of microarray data {#Sec4}
-------------------------------------

To confirm the differential expression of the genes revealed by microarray analysis, the genes of IDH2, FEM1A and SSBP1, which had different magnitudes of fold changes of gene expression, were selected for the assessment by qRT-PCR. The up-regulated expressions of these three genes were in accordance with those obtained from the microarray analysis (Figure [S1](#MOESM1){ref-type="media"}).

Clusters of co-expressed genes according to tissue or organ {#Sec5}
-----------------------------------------------------------

Hierarchical clustering of IDH2 (Fig. [1A](#Fig1){ref-type="fig"}), FEM1A (Fig. [1B](#Fig1){ref-type="fig"}) and SSPB1 (Fig. [1C](#Fig1){ref-type="fig"}) showing their 30 most co-expressed genes were screened by using Genevestigator tool. The color rectangles from white to red showed the percent of the gene expression potential. The genes expressed in the peripheral blood mononuclear cell or cardiomyocyte were considered as significant co-expressed genes.Figure 1Three target genes and their predicted co-expressed genes screened by Genevestigator. (**A**) IDH2 (**B**). FEM1A and (**C**). SSPB1 and their 30 most co-expressed genes in different tissues and cells.

Protein identification and quantification {#Sec6}
-----------------------------------------

A total of 3134 unique peptides recognizing in 787 proteins were detected by iTRAQ proteomic analysis. We identified 68 significant differentially expressed proteins (Table [2](#Tab2){ref-type="table"}), which had relative ratios higher than 1.5 or lower than 0.67. Among them, 49 proteins (72.1%) were up-regulated, while 19 proteins were down-regulated (27.9%).Table 2Differently expressed proteins between KD patients and the normal controls.UniProtKB accessionProtein nameGene nameFold changesp\|P02042\|HBD_HUMANHemoglobin subunit deltaHBD6.02sp\|P06401\|PRGR_HUMANProgesterone receptorPGR4.02sp\|P12004\|PCNA_HUMANProliferating cell nuclear antigenPCNA3.85sp\|P35228\|NOS2_HUMANNitric oxide synthase, inducibleNOS23.41sp\|Q9Y251\|HPSE_HUMANHeparanaseHPSE3.18sp\|P24941\|CDK2_HUMANCyclin-dependent kinase 2CDK23.06sp\|P02787\|TRFE_HUMANSerotransferrinTF2.72sp\|Q04206\|TF65_HUMANTranscription factor p65RELA2.68sp\|P10415\|BCL2_HUMANApoptosis regulator Bcl-2BCL22.55sp\|P00738\|HPT_HUMANHaptoglobinHP2.52sp\|P07288\|KLK3_HUMANProstate-specific antigenKLK32.48sp\|P01100\|FOS_HUMANProto-oncogene c-FosFOS2.44sp\|P02763\|A1AG1_HUMANAlpha-1-acid glycoprotein 1ORM12.43sp\|Q9Y3I1\|FBX7_HUMANF-box only protein 7FBXO72.38sp\|P04406\|G3P_HUMANGlyceraldehyde-3-phosphate dehydrogenaseGAPDH2.34sp\|P23528\|COF1_HUMANCofilin-1CFL12.29sp\|P02776\|PLF4_HUMANPlatelet factor 4PF42.26sp\|P25311\|ZA2G_HUMANZinc-alpha-2-glycoproteinAZGP12.22sp\|P55072\|TERA_HUMANTransitional endoplasmic reticulum ATPaseVCP2.18sp\|P13798\|ACPH_HUMANAcylamino-acid-releasing enzymeAPEH2.17sp\|P10720\|PF4V_HUMANPlatelet factor 4 variantPF4V12.09sp\|P03372\|ESR1_HUMANEstrogen receptorESR12.05sp\|Q9BSK4\|FEM1A_HUMANProtein fem-1 homolog AFEM1A1.97sp\|Q86UX7\|URP2_HUMANFermitin family homolog 3FERMT31.95sp\|P08123\|CO1A2_HUMANCollagen alpha-2(I) chainCOL1A21.94sp\|Q9Y490\|TLN1_HUMANTalin-1TLN11.93sp\|Q04837\|SSBP_HUMANSingle-stranded DNA-binding protein, mitochondrialSSBP11.91sp\|P02788\|TRFL_HUMANLactotransferrinLTF1.85sp\|P02790\|HEMO_HUMANHemopexinHPX1.84sp\|P07996\|TSP1_HUMANThrombospondin-1THBS11.84sp\|P01773\|HV312_HUMANImmunoglobulin heavy variable 3--30IGHV3--301.8sp\|P48735\|IDHP_HUMANIsocitrate dehydrogenase \[NADP\], mitochondrialIDH21.78sp\|P30041\|PRDX6_HUMANPeroxiredoxin-6PRDX61.76sp\|P27797\|CALR_HUMANCalreticulinCALR1.75sp\|P50213\|IDH3A_HUMANIsocitrate dehydrogenase \[NAD\] subunit alpha, mitochondrialIDH3A1.72sp\|P05164\|PERM_HUMANMyeloperoxidaseMPO1.7sp\|Q14766\|LTBP1_HUMANLatent-transforming growth factor beta-binding protein 1LTBP11.69sp\|Q13201\|MMRN1_HUMANMultimerin-1MMRN11.67sp\|P01011\|AACT_HUMANAlpha-1-antichymotrypsinSERPINA31.64sp\|A2BDB0\|ACTG_XENLAActin, cytoplasmic 2ACTG11.63sp\|P04264\|K2C1_HUMANKeratin, type II cytoskeletal 1KRT11.6sp\|O75306\|NDUS2_HUMANNADH dehydrogenase \[ubiquinone\] iron-sulfur protein 2, mitochondrialNDUFS21.6sp\|P01857\|IGHG1_HUMANIg gamma-1 chain C regionIGHG11.58sp\|P02774\|VTDB_HUMANVitamin D-binding proteinGC1.57sp\|P01009\|A1AT_HUMANAlpha-1-antitrypsinSERPINA11.56sp\|P02549\|SPTA1_HUMANSpectrin alpha chain, erythrocytic 1SPTA11.56sp\|Q8WWA0\|ITLN1_HUMANIntelectin-1ITLN11.55sp\|P55083\|MFAP4_HUMANMicrofibril-associated glycoprotein 4MFAP41.52sp\|Q8TDL5\|BPIB1_HUMANBPI fold-containing family B member 1BPIFB11.5sp\|P36980\|FHR2_HUMANComplement factor H-related protein 2CFHR20.66sp\|P55103\|INHBC_HUMANInhibin beta C chainINHBC0.65sp\|P20742\|PZP_HUMANPregnancy zone proteinPZP0.65sp\|Q13103\|SPP24_HUMANSecreted phosphoprotein 24SPP20.64sp\|P04278\|SHBG_HUMANSex hormone-binding globulinSHBG0.63sp\|P26572\|MGAT1_HUMANAlpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferaseMGAT10.61sp\|P00352\|AL1A1_HUMANRetinal dehydrogenase 1ALDH1A10.59sp\|Q96KN2\|CNDP1_HUMANBeta-Ala-His dipeptidaseCNDP10.58sp\|Q92496\|FHR4_HUMANComplement factor H-related protein 4CFHR40.57sp\|P05543\|THBG_HUMANThyroxine-binding globulinSERPINA70.57sp\|P29622\|KAIN_HUMANKallistatinSERPINA40.56sp\|O14791\|APOL1_HUMANApolipoprotein L1APOL10.52sp\|P08603\|CFAH_HUMANComplement factor HCFH0.49sp\|Q9UGM5\|FETUB_HUMANFetuin-BFETUB0.47sp\|P01019\|ANGT_HUMANAngiotensinogenAGT0.46sp\|P55056\|APOC4_HUMANApolipoprotein C-IVAPOC40.42sp\|P06312\|KV401_HUMANImmunoglobulin kappa variable 4--1IGKV4--10.42sp\|P08519\|APOA_HUMANApolipoprotein(a)LPA0.41sp\|Q02156\|KPCE_HUMANProtein kinase C epsilon typePRKCE0.31

Functional categorization, pathway and network analysis {#Sec7}
-------------------------------------------------------

Among the 68 differently expressed expression proteins, the proteins were categorized and displayed in the way of percentage by GO in three domains:23 biological processes (Fig. [2A](#Fig2){ref-type="fig"}), 16 molecular functions (Fig. [2B](#Fig2){ref-type="fig"}) and 16 cellular components (Fig. [2C](#Fig2){ref-type="fig"}). Fifteen function classes were categorized by COG. The function classifications and the number percentages of the protein in each classification were shown as follows: inorganic ion transport and metabolism (12%); cell motility (10%); translation, ribosomal structure and biogenesis (9%); nucleotide transport and metabolism (8%); cell wall/membrane/envelope biogenesis (8%); signal transduction mechanisms (8%); carbohydrate transport and metabolism (7%); energy production and conversion (6%); lipid transport and metabolism (6%); replication, recombination and repair (5%); amino acid transport and metabolism (5%); defense mechanism (4%); chromatin structure and dynamics (4%); cytoskeleton (3%) and those with unknown function (5%).Figure 2GO annotation of differential expression proteins in three domains: (**A**) biological process; (**B**) molecular function and (**C**) cellular component. The sectors of different colors show the percentage of each item.

Thirteen canonical pathways were obtained from IPA (Figure [S2](#MOESM1){ref-type="media"}). Z-score value was used to predict the activation state of the upstream regulator. The absolute z-score above 2 is considered significant. According to z-score, orange bar indicates that the activity pattern of this pathway was predicted; blue bar indicates that the inhibition pattern of this pathway was predicted and grey bar indicates that the pathway can't be assessed by this method. Ratio value indicates the number of molecules in a given pathway that meet cut criteria, divided by total number of molecules that make up that pathway^[@CR8]^. Among the pathways, TCA Cycle II (eukaryotic) pathway (Figure [S3](#MOESM1){ref-type="media"}) and NADH repair pathway (Figure [S4](#MOESM1){ref-type="media"}) were associated with the energy metabolism of cardiomyocyte. Isocitrate dehydrogenase 3 (NAD(+)) alpha (IDH3A) was the significant and up-regulated protein in TCA Cycle II (eukaryotic) pathway. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was the significant and up-regulated protein in NADH repair pathway.

STRING successfully identified 65 differently expressed proteins and resulted in one network (Fig. [3](#Fig3){ref-type="fig"}). The most dense network of associations was observed around GAPDH, while calreticulin (CALR) had five, IDH2 three, SSBP1 one and IDH3A one experimentally determined relationships. Altogether 16 genes were single nodes, with no associated genes. IDH2 has relationship with IDH3A. GAPDH has relationship with CALR and IDH2.Figure 3The interaction partners of the KD serous significant proteins network from STRING. Proteins are presented in the way of genes symbols. The implications of different colorful lines between the proteins are presented below the network map.

Discussion {#Sec8}
==========

KD is an endemic mitochondrial cardiomyopathy. The crista membranes of mitochondria in myocardium were swollen and enlarged. Meanwhile, the activity of oxidative phosphorylation enzymes was significant reduced in the mitochondria of KD patients^[@CR9]^. Mitochondria-related gene expression profiles have been shown to be different between KD patients and healthy controls^[@CR10]^.

These studies on interactions between multiple genes are becoming more and more meaningful than a single gene analysis in order to gain deeper understanding on the pathogenesis of complex diseases. Investigation of the genes that co-expressed in the same tissue with the target gene may be an important approach to identify the interacting genes. In this study, we used microarray to screen target genes associated with KD. Then, we combined the co-expression analysis and proteomics analysis to verify significant co-expressed genes and the proteins they encode with the target genes. Finally, we applied function categorization, pathway and network analysis to analyze these differently expressed proteins.

In our study, microarray analysis revealed that IDH2, FEM1A and SSBP1 were up-regulated genes in KD patient compared with the normal group. While proteomic iTRAQ analysis showed that proteins IDH2, FEM1A, SSBP1, CALR and NADH: ubiquinone oxidoreductase core subunit S2 (NDUFS2) were present at elevated level in KD patients' serum. Genevestigator analysis predicted also CALR and NDUFS2 to co-express with IDH2 in peripheral blood mononuclear cell and cardiomyocyte, and their elevated protein levels in KD sera were confirmed by iTRAQ. Target gene analysis of FEM1A and SSBP1 gave no predicted co-expressed genes, which were common with the differences at protein level.

In mitochondria, IDH2 encodes isocitratedehydrogenase2, which catalyzes isocitric acid to generate α-ketoglutarate in tricarboxylic acid cycle and restores the NAD^+^ or NADP^+^ to NAD or NADP. These two processes are important for the energy metabolism, biological synthesis and anti-oxidative stress^[@CR11]^. Simvastatin can decrease the NAD in myocardium of mice, which can relieve myocardial ischemia-reperfusion injury. In this study, IDH2 was up-regulation in KD than normal control. IDH2 caused the up-regulation of NAD, which may lead to the cardiomyopathy of KD.

FEM1A is also a mitochondrial protein, and preferentially expressed in organs enriched in mitochondria, such as cardiac muscle, brain and liver. It has also been observed that FEM1A expression is increased in hearts from mice subjected to ischemia--reperfusion injury. It is localized within mitochondria of C2C12 myoblasts and cardiomyocytes^[@CR12]^. In this study, FEM1A was up regulated in KD, which indicates the mitochondrial dysfunction in KD may associate with FEM1A.

SSBP1 is believed to maintain the stability of genome, and coordinate the functions of DNA polymerase and the mitochondrial DNA helicase^[@CR13]^. Over-expression of SSBP1 increased the amount of elongated or fragmented mitochondria in murine C2C12 myoblast cells. On the other hand, the silencing of SSBP1 by RNA interference led to an increase in fragmented or elongated mitochondria in the cell, suggesting that SSBP1 was involved in the processes of mitochondrial fusion and fission. The expression of SSBP1 changes may cause the abnormality of mitochondrial morphology and function^[@CR14]^. Thus, it is obvious that the increased expression of SSBP1, as noticed in KD samples of this study, may cause the abnormalities of mitochondrial morphology and function.

CALR is a 46 kDa, ER-lumenal Ca2^+^-binding protein and molecular chaperone, which is required for proper heart development, and is induced in animal models of hypertrophic heart disease^[@CR15]^. CALR expression increased in the pathologic heart, where it modulates hypertrophic growth, potentially reducing the impact of the pathology^[@CR16]^. The pathological feature of KD is ventricular dilatation^[@CR17]^, thus, the ventricular dilatation of KD may associate with elevated level of CALR noticed in this study.

NDUFS2 is located in the hydrophilic arm of mitochondrial respiratory chain complex I, close to the membrane domain^[@CR18]^, and it has been shown that NDUFS2 mutation affects mitochondrial respiratory chain complex I enzymatic function^[@CR19]^. In this study, NDUFS2 was up regulated in KD patients. The result indicates that the mitochondrial respiratory chain complex I enzymatic dysfunction in KD may be associated with NDUFS2.

In TCA Cycle II (Eukaryotic) pathway, IDH3A was up regulated. Among the mammalian, IDH3A is supposed to play a major role in mitochondrial isocitrate decarboxylation in the TCA cycle^[@CR20]^. GAPDH is a multifunctional protein that also mediates cell death under oxidative stress. In NADP repair pathway, it was up regulated. It reported previously that the active-site cysteine (Cys-152) of GAPDH plays an essential role in oxidative stress-induced aggregation of GAPDH associated with cell death. In isolated mitochondria, aggregates of WT-GAPDH directly induced mitochondrial swelling and depolarization, whereas mixtures containing aggregates of Cys-152 GAPDH reduced mitochondrial dysfunction^[@CR21]^. The dysfunction of mitochondria in KD patient is verified by many studies as mentioned above. The up regulated of IDH3Aand GAPDH may play roles in the dysfunction of mitochondria in KD.

IDH2 has relationship with IDH3A. IDH3A and IDH2 both belong to the isocitrate dehydrogenase gene family^[@CR22]^. GAPDH has relationship with CALR and IDH2 separately in protein network. GAPDH and IDH2 are both associated with the function of mitochondria^[@CR23]^. The interactions of GAPDH with IDH2 and CALR will be our next step study aims.

In conclusion, Genevestigator can forecast the protein expression of the co-expression genes CALR and NDUFS2 of IDH2 in the same tissue or organ. The genes IDH2, FEM1A, SSBP1, CALR, NDUFS2, IDH3A, GAPDH and their encoded proteins may play important roles in the pathogenesis of KD. In addition, TCA Cycle II (Eukaryotic) pathway and NADP repair pathway may also participate in the pathogenesis of KD. Overall, the gene microarray combined iTRAQ comparative proteomics analysis may be a beneficial approach to reveal the molecular mechanisms of other diseases.

Materials and Methods {#Sec9}
=====================

Collection of peripheral blood samples {#Sec10}
--------------------------------------

Patients with KD came from the KD-affected areas, which are Xunyi and Huangling Counties at Shaanxi Province of China. Clinical evaluation was according to the KD diagnosis criteria in China (WS/T 210--2011). Peripheral blood samples were collected from 112 KD patients (61 females and 51 males, 43--70 years old) and 112 normal controls (60 females and 52 males, 45--67 years old) were matched by age and gender. Each sample is 2.5 ml. Whole blood samples from 106 KD patients and 106 normal controls were collected in heparinized vacutainer tubes containing RNA stabilizing solution. Sera of other 6 KD and 6 normal controls were collected after centrifugation of whole blood, 3000 rpm, 5 min. All samples were stored at −80 °C.

The normal control subjects didn't contain cardiovascular disease, hypertension or diabetes patients. Every subject involved in the investigation signed the informed consent. This investigation obtained the approval of Human Ethics Committee of Xi'an Jiaotong University, Xi'an, Shaanxi, China. We confirmed that all experiments were performed in accordance with the relevant guidelines and regulations.

RNA extraction and microarray analysis {#Sec11}
--------------------------------------

Peripheral blood mononuclear cell (PBMC) RNA was extracted from the peripheral blood of 106 KD and 106 normal controls. One hundred KD (53 females and 47 males, 43--70 years old) and 100 normal controls (52 females and 48 males, 46--66 years old) were used for the oligonucleotide microarray. The rest of the RNA samples were used for quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. The protocol of PBMC RNA extraction and oligonucleotide microarray analysis were done as previously described^[@CR24]^. The oligonucleotide microarray contained altogether 78 probes for the 78 differentially expressed genes^[@CR5]^. Fold changes ≥3 and ≤0.33 between KD and control samples were considered as up- and down-regulated genes, respectively.

Quantitative RT- PCR {#Sec12}
--------------------

Six KD (4 females and 2 males, 45--60 years old) and 6 normal controls (4 females and 2 males, 45--58 years old) were matched by gender and age. RNA was extracted from the peripheral blood of all the samples. To validate the microarray results, three differently expressed genes isocitrate dehydrogenase \[NADP(+)\] 2, mitochondrial (IDH2), fem-1 homolog A (FEM1A) and single stranded DNA binding protein 1 (SSBP1) genes were selected as three differently expressed target genes for qRT-PCR. qRT-PCR was done by following the manufacturer's recommended protocol (Invitrogen, Germany). The qRT-PCR data were log-transformed to ensure normal distribution and analyzed using paired *t*-tests.

Co-expression gene forecast analysis {#Sec13}
------------------------------------

Genevestigator (<https://genevestigator.com/gv/>) is a powerful tools search engine for gene expression with advanced analysis possibilities, including the search for genes that are specifically expressed under certain conditions, and the search for groups of genes sharing similar expression patterns by means of clustering and biclustering algorithms^[@CR25]^. In this study, the co-expression function of Genevestigator was used to find co-regulated genes with a gene of interest. IDH2, FEM1A and SSBP1 were chosen as target genes separately. Firstly, in order to find conditions relevant for the gene of interest, perturbations tool was applied. *P*-value 0.05 and fold-change 2 or 0.5 were selected as criteria. Secondly, in order to find other genes regulated under the same conditions, co-expression tool was used to find the top 30 genes most likely co-expressed with the target gene across these relevant conditions. Finally, hierarchical clustering tool was applied to cluster the top 30 co-expressed genes by similarity across anatomical parts.

Mass spectrometry (LC-MS/MS) analysis {#Sec14}
-------------------------------------

Sera of 6 KD (4 females and 2 males, 58--66 years old) and 6 normal controls (4 females and 2 males, 55--67 years old) were used for iTRAQ analysis. The total protein of each sample was extracted using ProteoMiner^TM^ Kits (Bio-Rad, USA) according to the instruction. One hundred μg total protein was taken from each sample. After digested with Trypsin Gold (Promega, USA), the tryptic peptides were processed using iTRAQ reagent (Applied Biosystems, USA) according to the manufacturer's protocol. LC-20AB HPLC Pump system (Shimadzu, Japan) was used for SCX chromatography. TripleTOF 5600 System (AB SCIEX, USA) was used for data acquisition.

Mascot 2.3.02 (Matrix Science, UK) was used for protein identification and quantification. The protein abundance with fold changes ≤0.67 and ≥1.5 (KD patients/normal ones) was considered as down-and up- regulated ones, respectively.

Function analysis {#Sec15}
-----------------

Functional annotations of the differently expressed proteins were conducted using Blast2 GO (Gene Ontology) program against the non-redundant protein database (NR, NCBI). GO is an international standardization system of gene function classification. It has three ontologies, which can describe molecular function, cellular component, and biological process. COG (Cluster of Orthologous Groups of proteins) database (<http://www.ncbi.nlm.nih.gov/COG/>) was used to classify and group these identified proteins.

IPA (Ingenuity Pathway Analysis, <http://www.ingenuity.com>) is a repository of biological interactions and functional annotations from many relations between proteins, genes, complexes, cells, tissues, metabolites, drugs and diseases. IPA selected sources and databases from NCBI databases (for instance, Entrez Gene, Ref-Seq, OMIM disease associations, miRNA--mRNA target databases, GWAS databases and KEGG)^24^. The function of "Canonical pathway" in IPA was used to analyze the significant pathway. The genes from the dataset that met the log ratio cut-off of 3were considered relevant to be included in the analyses. We chose pathways that were statistically significant with a *P*-value ≤ 0.05 using the Fisher's exact test.

STRING database (functional protein association networks, <http://string.embl.de/>) provides a score for each gene-gene or protein-protein interaction, which is computed as the joint probability of the probabilities from the different evidence channels (e.g., protein interaction, fusion, co-expression, text mining), correcting for the probability of randomly observing an interaction^[@CR26]^. All the differently expressed proteins were analyzed using STRING-10 server. An interactome network was built for these sets of proteins to find out protein-protein interaction and to predict functional associations.

Data Availability {#Sec16}
-----------------

The datasets generated during the current study are available from the corresponding author on reasonable request.
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